Summary
Plasma levels of amitriptyline and nortriptyline were measured twice weekly in 62 patients treated for three weeks with i.m. amitriptyline 120 mg/day. In half the patients the ratio of amitriptyline to nortriptyline was under 1 and in the other half it was greater than 1. 30 of these 62 patients were clinically monitored with the Hamilton Rating Scale and the side effects of the drug were recorded. There was no correlation between plasma level of the drug and its side effects, but there was a statistically significant curvilinear correlation between the plasma levels of amitriptyline plus nortriptyline and nortriptyline alone, and the clinical effect. The practical value of this type of investigation was demonstrated by showing that patients whose drug plasma level was not in the therapeutic range, were clinically improved after adjustment of the dose. The plasma level of amitriptyline plus nortriptyline must lie between 60 to 220 ng/ml, and that of nortriptyline between 60 to 140 ng/ml, to obtain the best clinical effect. Associated treatments, age, weight and sex of patients, and the type of depression did not appear significantly to affect the plasma level of the drug.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Alexanderson, B., Evans, D. A., Sjöqvist, F.: Steady State plasma levels of nortriptyline in twins: influence of genetic factors and drug therapy. Br. med. J.1969/IV, 764–768
Angst, J., Rothweiler, R.: Blood levels and clinical effects of maprotiline (Ludiomil®). In classification and prediction of outcome of depression. Symposia Medica Hoechst8, 237–244 (1974)
Asberg, M.: Plasma nortriptyline levels. Relationship to clinical effects. Clin. Pharmacol. Ther.16, 215–229 (1974)
Asberg, M.: Treatment of Depression with Tricyclic Drugs. Pharmacokinetic and Pharmacodynamic Aspects. Pharmakopsychiatrie. Neuropsychopharmacologie9, 18–26 (1976)
Asberg, M., Cronholm, B., Sjöqvist, F., Tuck, D.: Relationship between plasma level and therapeutic effect of nortriptyline. Br. med. J.1971/III, 331–334
Braithwaite, R. A., Goulding, R., Theand, G., Bailey, J., Coppen, A.: Plasma concentration of amitriptyline and clinical response. Lancet1972/I, 1297–1300
Burrows, G. D.: Clinical and Pharmacological Studies in depressive illness. M. D. Thesis, University of Melbourne, 1973
Burrows, G. D., Davies, B., Scoggins, B. A.: Plasma concentration of nortriptyline and clinical response in depressive illness. Lancet1972/II, 619–623
Burrows, G. D., Scoggins, B. A., Turecek, L. R., Davies, B.: Plasma nortriptyline and clinical response. Clin. Pharmacol. Ther.16, 639–644 (1974)
Coppen, A.: The effective dosage of antidepressants. Postgrad. med. J.52, (Suppl. 3), 72–74 (1976)
Gram, L., Reisby, N., Ibsen, I., Nagy, A., Dencker, S., Bech, P., Petersen, G.: Christiansen, J.: Plasma levels and antidepressive effect of imipramine. Clin. Pharmacol. Ther.19, 318–324 (1975)
Gurney, C., Roth, M., Garside, R. F., Kerr, T. A., Schapira, K.: Studies in the classification of affective disorders. Br. J. Psychiat.121, 162–166 (1972)
Hammer, W., Ideström, C. M., Sjöqvist, F.: Chemical control of antidepressant drug therapy, in Antidepressant Drugs, (ed. S. Garattini and M. N. G. Dukes) p. 301–310. Amsterdam: Excerpta Medica 1967
Hammer, W., Martens, S., Sjöqvist, F.: A comparative study of the metabolism of desmethylimipramine, nortriptyline, and oxyphenylbutazone in man. Clin. Pharmacol. Ther.10, 44–49 (1969)
Hammer, W., Sjöqvist, F.: Plasma levels of monomethylated tricyclic antidepressants during treatment with imipramine-like compounds. Life Sci.6, 1895–1903 (1967)
Knesevich, J. W., Biggs, J. T., Clayton, J., Ziegler, V. E.: Validity of the Hamilton Rating Scale for depression. Br. J. Psychiat.131, 49–52 (1977)
Kragh-Sörensen, P., Asberg, M., Eggert-Hansen, C.: Plasma nortriptyline levels in endogenous depression. Lancet1973/I, 113–115
Kragh-Sörensen, P., Eggert-Hansen, C., Baastrup, P., Hvidberg, E. F.: Self inhibiting action of nortriptylin's antidepressive effect at high plasma levels. Psychopharmacologia,45, 305–312 (1976)
Kupfer, D. J., Hanin, I., Spiker, D. G., Grau, T., Coble, P.: Amitriptyline plasma levels and clinical response in primary depression. Clin. Pharmacol. Ther.22, 904–911 (1977)
Montgomery, S.: The relationship between plasma concentrations of amitriptyline and therapeutic response. Paper read to the British Academy of Psychopharmacology, London, July 1, 1975
Moody, J. P., Tait, A. C., Todrick, A.: Plasma levels of imipramine and desmethyl-imipramine during therapy. Br. J. Psychiat.,113, 183–193 (1967)
Olivier-Martin, R., Marzon, D., Buchsenschutz, E., Pichot, P., Boissier, J.: Concentrations plasmatiques de l'imipramine et de la desmethylimipramine et effet antidépresseur au cours d'un traitement contrôlé. Psychopharmacologia,41, 187–195 (1975)
Philippe, J.: Les méthodes statistiques en pharmacic et en chimie, p. 152–181. Paris: Masson 1967
Sjöqvist, F.: A pharmacokinetic approach to the treatment of depression. Int. Pharmacopsychiat.,6, 147–169 (1971)
Tillement, J. P.: Pharmacocinétique des antidépresseurs. Thérapie,28, 249–268 (1973)
Volmat, R., Bechtel, P., Allers, G., Vandel, B., Vandel, S.: Mesure de la concentration plasmatique et effet antidépresseur de l'amitriptyline. Thérapie,32, 309–319 (1977)
Whyte, S., MacDonald, A., Naylor, G., Moody, J.: Plasma concentrations of protriptyline and clinical effects in depressed Women. Br. J. Psychiat.,128, 384–390 (1976)
Ziegler, V., Co., B., Taylor, J., Clayton, P., Biggs, J.: Amitriptyline plasma levels and therapeutic response. Clin. Pharmacol. Ther.,19, 795–801 (1976)
Ziegler, V., Clayton, P., Taylor, J., Co, B., Biggs, J.: Nortriptyline plasma levels and therapeutic response. Clin. Pharmacol. Ther.,20, 458–462 (1976)
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vandel, S., Vandel, B., Sandoz, M. et al. Clinical response and plasma concentration of amitriptyline and its metabolite nortriptyline. Eur J Clin Pharmacol 14, 185–190 (1978). https://doi.org/10.1007/BF02089958
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02089958